Difference between revisions of "Levamisole (Ergamisol)"
Jump to navigation
Jump to search
m |
m |
||
| Line 13: | Line 13: | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| + | [[Category:Antihelminthic]] | ||
[[Category:Breast cancer medications (historic)]] | [[Category:Breast cancer medications (historic)]] | ||
[[Category:Colon cancer medications (historic)]] | [[Category:Colon cancer medications (historic)]] | ||
Latest revision as of 10:37, 4 July 2023
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 1990-06-18: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & SWOG S8591)
History of changes in EMA indication
- 1966-06-14: EURD
Also known as
- Brand name: Ergamisol